Fremdkapital Veränderung Datum
Agenus USD 153.98M 15.68M 2026-03
Amgen USD 51.61B 250M 2026-09
Arrowhead Research USD 824.07M 401.34M 2026-06
AstraZeneca USD 28.8B 2.79B 2026-09
BioMarin Pharmaceutical USD 3.51B 12.96M 2026-09
Bristol-Myers Squibb USD 41.85B 244M 2026-09
Daiichi Sankyo JPY 499.93B 75M 2026-09
Eli Lilly USD 46.99B 872M 2026-09
Halozyme Therapeutics USD 2.94B 1.01B 2026-09
Heron Therapeutics USD 140.64M 975K 2025-12
Intrexon USD 0 198.67M 2024-06
Ionis Pharmaceuticals USD 1.77B 140.62M 2026-09
Karyopharm Therapeutics USD 264.49M 13.73M 2026-03
Ligand Pharmaceuticals USD 1.13B 679.7M 2026-06
MacroGenics USD 163.16M 94.44M 2026-06
Neurocrine Biosciences USD 169.5M 500K 2023-03
Pfizer USD 60B 498M 2026-09
Regeneron Pharmaceuticals USD 1.99B 400K 2026-09
Rigel Pharmaceuticals USD 0 0 2024-09
Sangamo BioSciences USD 0 0 2022-06
Ultragenyx Pharmaceutical USD 1.13B 2M 2026-06
Veracyte USD 0 0 2025-03